Skip to main content

Advertisement

Log in

Hodgkin lymphoma as a complication of primary Sjögren’s syndrome

  • Case Report
  • Published:
Modern Rheumatology

Abstract

Sjögren’s syndrome (SS) is a chronic autoimmune disease that is characterized by lymphocytic infiltration of the exocrine glands, mainly the salivary and lachrymal glands, usually manifesting with xerostomia and xerophthalmia. Around 50% of patients with primary SS develop systemic complications, lymphoma being the most feared of these. The majority of these neoplasias originate from B cells and are of the non-Hodgkin type. We describe here a rare case of SS in which the patient developed a Hodgkin lymphoma. We also review the literature on this subject.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jonsson RH, Haga J, Gordon TP. Sjögren’s syndrome. In: Koopman WJ, editor. Arthritis, allied conditions—a textbook of rheumatology, vol 2, 14th edn. Philadelphia: Lippincott Williams & Wilkins; 2001.

    Google Scholar 

  2. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164(12):1275–84.

    Article  PubMed  Google Scholar 

  3. Tonami H, Matoba M, Kuginuki Y, Yokota H, Higashi K, Yamamoto I, et al. Clinical and imaging findings of lymphoma in patients with Sjogren syndrome. J Comput Assist Tomogr. 2003;27:517–24.

    Article  PubMed  Google Scholar 

  4. Garcia-Carrasco M, Ramos-Casals M, Cervera R, Font J. Primary Sjogren’s syndrome and lymphatic proliferation. Med Clin (Barc). 2000;114:740–6.

    CAS  Google Scholar 

  5. Ramos-Casals M, Font J, Garcia-Carrasco M, Brito MP, Rosas J, Calvo-Alen J, et al. Primary Sjogren syndrome: hematologic patterns of disease expression. Medicine (Baltimore). 2002;81:281–92.

    Article  Google Scholar 

  6. Masaki Y, Sugai S. Lymphoproliferative disorders in Sjogren’s syndrome. Autoimmun Rev. 2004;3:175–82.

    Article  PubMed  Google Scholar 

  7. Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol. 2006;18:129–34.

    Article  PubMed  Google Scholar 

  8. Fox RI. Sjogren’s syndrome. Lancet. 2005;366:321–31.

    Article  PubMed  CAS  Google Scholar 

  9. Nagai M, Sasaki K, Tokuda M, Tasaka T, Goto T, Ohnishi M, et al. Hodgkin’s disease and Sjogren’s syndrome. Eur J Haematol. 1993;50:180–2.

    Article  PubMed  CAS  Google Scholar 

  10. Martin-Santos JM, Carretero L, Armentia A, Alonso E, Gil I. Hodgkin’s disease occurring in primary Sjogren’s syndrome. Ann Rheum Dis. 1990;49:646–7.

    Article  PubMed  CAS  Google Scholar 

  11. Vivancos J, Bosch X, Grau JM, Coca A, Font J. Development of Hodgkin’s disease in the course of primary Sjogren’s syndrome. Br J Rheumatol. 1992;31:561–3 (Erratum in Br J Rheumatol 1993;32:157).

    Google Scholar 

  12. Navarro B, Yebra M, Romero J, Suarez-Massa D. Hodgkin lymphoma associated with primary Sjogren’s syndrome. Med Clin (Barc). 2001;116:636.

    CAS  Google Scholar 

  13. Kuppers R, Schwering I, Brauninger A, Rajewsky K, Hansmann ML. Biology of Hodgkin’s lymphoma. Ann Oncol. 2002;13[Suppl 1]:11–8.

    PubMed  Google Scholar 

  14. Rubin P, Holt JF. Secretory sialography in diseases of the major salivary glands. Am J Roentgenol Radium Ther Nucl Med. 1957;77:575–98.

    PubMed  CAS  Google Scholar 

  15. Rothman S, Block M, Hauser FV. Sjogren’s syndrome associated with lymphoblastoma and hypersplenism. Arch Derm Syphilol. 1951;63:642.

    CAS  Google Scholar 

  16. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren’s syndrome. Arthritis Rheum. 2002;46:741–7.

    Article  PubMed  Google Scholar 

  17. Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S, et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin’s lymphoma: a case-control study. Am J Epidemiol. 2005;162:1153–61.

    Article  PubMed  Google Scholar 

  18. Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sjogren’s syndrome. Clin Exp Immunol. 1972;10:199–221.

    PubMed  CAS  Google Scholar 

  19. Zulman J, Jaffe R, Talal N. Evidence that the malignant lymphoma of Sjogren’s syndrome is a monoclonal B-cell neoplasm. N Engl J Med. 1978;299:1215–20.

    Article  PubMed  CAS  Google Scholar 

  20. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE. Classification criteria for Sjogren`s syndrome: a revised version of European criteria proposed by the America-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

MS is currently receiving a scholarship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). The authors acknowledge the technical assistance of Dr. Silene Barreto and Dr. Eduardo José Bittencourt (pathologists).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mittermayer Barreto Santiago.

About this article

Cite this article

Lima, I., Carneiro, A.S.B., Amorim, C.A. et al. Hodgkin lymphoma as a complication of primary Sjögren’s syndrome. Mod Rheumatol 18, 200–202 (2008). https://doi.org/10.1007/s10165-008-0030-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-008-0030-7

Keywords

Navigation